# Efficacy of Montelukast on STEMl Patients

> **NCT07320625** · PHASE3 · RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 512 (estimated)

## Conditions studied

- Myocardial Infarction (MI)

## Interventions

- **DRUG:** Montelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07320625
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 512 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07320625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07320625, "Efficacy of Montelukast on STEMl Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07320625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*